Source: Atherosclerosis Supplements. Conference titles: European Atherosclerosis Society Congress (EAS). Unidade: FCF
Subjects: TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS, EXPRESSÃO GÊNICA
ABNT
CERDA, Alvaro et al. Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 ago. 2024. , 2011APA
Cerda, A., Genvigir, F. D. V., Rohde, C. B. S., Issa, M., Cavalli, S. A., Bertolami, M. C., et al. (2011). Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Cerda A, Genvigir FDV, Rohde CBS, Issa M, Cavalli SA, Bertolami MC, Hirata MH, Hirata RDC. Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. 2011 ; 12( 1): 45 res. 201.[citado 2024 ago. 18 ]Vancouver
Cerda A, Genvigir FDV, Rohde CBS, Issa M, Cavalli SA, Bertolami MC, Hirata MH, Hirata RDC. Atorvastatin and hormone replacement therapy affect expression of genes regulating the reverse cholesterol transport in mononuclear cells from postmenopausal women. Atherosclerosis Supplements. 2011 ; 12( 1): 45 res. 201.[citado 2024 ago. 18 ]